Travere Therapeutics (TVTX) Selling, General & Administrative (2011 - 2026)
Travere Therapeutics (TVTX) Selling, General & Administrative (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
SG&A (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
17.02 Mn |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
1.32 Mn |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-37.00 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-1.52 Mn |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
2.17 Mn |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
217,225.00 |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
493.70 Mn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
-7.36 Mn |
| 10 |
Travere Therapeutics |
5.07 Bn |
4.99 Bn |
102.38 Mn |
80.25 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
80.25 Mn |
| Dec 31, 2025 |
101.69 Mn |
| Sep 30, 2025 |
86.45 Mn |
| Jun 30, 2025 |
76.22 Mn |
| Mar 31, 2025 |
60.41 Mn |
| Dec 31, 2024 |
69.50 Mn |
| Sep 30, 2024 |
65.62 Mn |
| Jun 30, 2024 |
64.78 Mn |
| Mar 31, 2024 |
64.22 Mn |
| Dec 31, 2023 |
63.59 Mn |
| Sep 30, 2023 |
67.80 Mn |
| Jun 30, 2023 |
68.20 Mn |
| Mar 31, 2023 |
65.95 Mn |
| Dec 31, 2022 |
57.09 Mn |
| Sep 30, 2022 |
52.42 Mn |
| Jun 30, 2022 |
52.98 Mn |
| Mar 31, 2022 |
46.79 Mn |
| Dec 31, 2021 |
18.48 Mn |
| Sep 30, 2021 |
36.07 Mn |
| Jun 30, 2021 |
34.97 Mn |
